Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I
Clinical trial NCT00277758 · TERMINATED
Trial details
- NCT number
- NCT00277758
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2006-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.